Across TCGA pan-cancer cohorts, LRRC14 mass-spec protein differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of LRRC14’s most consistent transcriptional readouts.
The strongest signal is observed in colon adenocarcinoma (COAD), where LRRC14 mass-spec protein is repressed in tumor relative to normal tissue. In most cancer types LRRC14 is over-expressed in tumor, although a few such as COAD and LSCC show the opposite, repressed pattern.
COAD and LSCC are the cancer types where LRRC14 tumor–normal differential expression is most reproducible.